RRA
XERS icon

Round Rock Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Round Rock Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Sell
46,102
-50,714
-52% -$324K 0.05% 251
2026
Q1 		$562K Hold
96,816
– – 0.09% 180
2025
Q4 		$760K Buy
96,816
+33,044
+52% +$260K 0.11% 140
2025
Q3 		$582K Buy
+63,772
New +$424K 0.09% 153

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Round Rock Advisors's XERS Position: Q2 2026 in Review

Round Rock Advisors reduced its Xeris Biopharma Holdings (XERS) stake by 52% in Q2 2026, selling an estimated $324K and leaving 46,102 shares worth $365K. The position accounts for 0.05% of the portfolio, ranked #251.

Round Rock Advisors first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. The position peaked at $760K in Q4 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Round Rock Advisors held 46,102 shares of Xeris Biopharma Holdings worth $365K as of Q2 2026.
  • Round Rock Advisors sold 50,714 Xeris Biopharma Holdings shares in Q2 2026, an estimated $324K.
  • Xeris Biopharma Holdings made up 0.05% of Round Rock Advisors's portfolio in Q2 2026, its #251 holding.
  • Round Rock Advisors first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
  • Round Rock Advisors's Xeris Biopharma Holdings position peaked at $760K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.